Earning Analysis
Welcome to our in-depth analysis of (ITCI) earnings, offering investors a detailed look into the company’s financial performance, revenue trends, earnings per share (EPS), and market reactions. This page provides a comprehensive overview of earnings history, forecasts, and key financial metrics, empowering you with the data needed to make informed investment decisions. Whether you're tracking quarterly results, analyzing earnings surprises, or exploring future projections, our detailed breakdown covers it all.
Earnings Forecast
Revenue
EPS
Currency: USD
Actual
Estimate
Surprise Analysis
FY2024Q3 | 2024-10-30 | Pre-Market | -0.18 | -0.25 | -38.89 | 172.35M | 175.38M | +1.75 | +11.36 | +16.27 |
FY2024Q2 | 2024-08-07 | Pre-Market | -0.18 | -0.16 | +11.11 | 157.88M | 161.39M | +2.22 | -5.81 | -3.63 |
FY2024Q1 | 2024-05-07 | - | -0.31 | -0.16 | +48.39 | 141.44M | 144.87M | +2.42 | +0.28 | -6.60 |
FY2023Q4 | 2024-02-22 | - | -0.44 | -0.30 | +31.82 | 135.67M | 132.10M | -2.63 | -1.84 | -2.93 |
FY2023Q3 | 2023-11-02 | - | -0.59 | -0.25 | +57.63 | 119.23M | 126.17M | +5.83 | +2.97 | +8.39 |
FY2023Q2 | 2023-08-03 | - | -0.62 | -0.45 | +27.42 | 106.82M | 110.79M | +3.72 | -3.25 | -4.60 |
- | 2023-05-04 | - | -0.63 | -0.46 | +26.98 | - | - | - | -2.02 | +5.04 |
- | 2023-03-01 | - | -0.62 | -0.45 | +27.42 | - | - | - | +0.59 | -5.89 |
- | 2022-11-03 | - | -0.86 | -0.57 | +33.72 | - | - | - | +13.20 | +9.12 |
- | 2022-08-09 | - | -0.79 | -0.92 | -16.46 | - | - | - | -4.28 | -10.74 |
ITCI Earnings Analysis
Our earnings analysis provides a granular look at the company’s performance across recent fiscal quarters, highlighting key metrics such as revenue, EPS, and operating margins. By examining actual results against analyst estimates, we uncover trends and surprises that drive stock price movements, offering valuable insights for both short-term traders and long-term investors.
In the most recent quarter, reported performance for FY2024Q3, announced on 2024-10-30. The company achieved an EPS of -0.25, compared to analyst estimates of -0.18 by -38.89% . Revenue for the quarter reached 175.38M compared to expectations of 172.35M by 1.75% .
The stock price reacted with a 11.36% one-day change and a 16.27% five-day change following the earnings release. These movements reflect market reaction in growth trajectory and strategic initiatives.
ITCI Earnings Forecast
Looking ahead, (ITCI) remains a focal point for investors seeking growth opportunities. Analyst forecasts for 2025/Q1 project quarter revenue of 205.53M and an EPS of .
However, recent estimate revisions provide additional context. Over the past three months, revenue estimates for FY2025 have been No Change by 0%, while EPS estimates have been No Change by 0%. For the upcoming , revenue estimates have been adjusted No Change by % . These revisions correlate with a % change in stock price over the same period, suggesting potential buying opportunities for investors who believe in long-term fundamentals.
The relationship between earnings forecast revisions and stock price movements is critical for investors. Positive revisions in revenue or EPS often signal strengthening fundamentals, making temporary price dips attractive entry points. Conversely, downward revisions may reflect short-term challenges.
Estimate Revision
The chart shows the correlation between ITCI's stock price and earnings forecast revisions. Positive revisions in Revenue or EPS often strengthen the stock's fundamentals, making price dips potential buying opportunities.
Revenue Estimates for FY2025
No Change

0.00%
In Past 3 Month
Revenue Estimates for Q1 2025
No Change

0.00%
In Past 3 Month
1Y
3Y
5Y
Annual FY 2025
Currency: USD
1Y
3Y
5Y
--
Revenue Estimate-Annual FY 2025:950.31M
--
EPS Estimate-Annual FY 2025:0
—
Stock Price131.87
ITCI Revenue and EPS Performance: A Historical Perspective
revenue and earnings per share (EPS) performance over recent quarters provides a clear picture of its financial health. Below is a detailed breakdown of the company’s earnings history, showcasing actual results, analyst estimates, and surprise percentages for key fiscal quarters:
FY2024Q3 (2024-10-30,Pre-Market):
EPS: -0.25 (Actual) vs.-0.18 (Estimate) (-38.89%)
Revenue: 175.38M (Actual) vs. 172.35M (Estimate) (1.75%)
Price Reaction: 11.36%(1-Day), 16.27%(5-Day)
FY2024Q2 (2024-08-07,Pre-Market):
EPS: -0.16 (Actual) vs.-0.18 (Estimate) (11.11%)
Revenue: 161.39M (Actual) vs. 157.88M (Estimate) (2.22%)
Price Reaction: -5.81%(1-Day), -3.63%(5-Day)
FY2024Q1 (2024-05-07,):
EPS: -0.16 (Actual) vs.-0.31 (Estimate) (48.39%)
Revenue: 144.87M (Actual) vs. 141.44M (Estimate) (2.42%)
Price Reaction: 0.28%(1-Day), -6.60%(5-Day)
Earnings Reaction
The chart below shows how ITCI performed 10 days before and after its earnings report, based on data from the past quarters. Typically, ITCI sees a -2.74% change in stock price 10 days leading up to the earnings, and a -3.17% change 10 days following the report. On the earnings day itself, the stock moves by +1.12%. This data can give you a slight idea of what to expect for the next quarter's release.
For example, in SEP/2024, the stock changed -0.84% on the day following the earnings release and then changed by 3.22% over the next 10 days. These patterns provide investors with valuable insights into potential price movements and help inform trading strategies around earnings events.
Transcript Summary
Intra-Cellular Therapies, Inc. (ITCI) Q3 2024 Earnings Call Summary
Positive
2024-10-30
The earnings call summary highlights strong financial performance with a 39% YoY increase in net sales and a robust cash position. The company is expanding its sales force and advancing its pipeline, indicating growth potential. Despite regulatory and supply chain risks, the optimistic guidance and increased sales force suggest positive momentum. The Q&A section supports this sentiment, with management expressing confidence in CAPLYTA's market opportunity. Overall, the sentiment is positive, but cautious due to potential risks and uncertainties.
Intra-Cellular Therapies, Inc. (ITCI) Q2 2024 Earnings Call Summary
Neutral
2024-08-07
The earnings call presents mixed signals. The strong financial performance, with a 46% YoY increase in CAPLYTA sales and raised sales guidance, is positive. However, increased expenses and lack of clarity on profitability and sales force expansion pose concerns. The Q&A reveals management's confidence but also highlights some evasive responses. The absence of a share repurchase program and the increased SG&A expenses temper enthusiasm. Overall, the sentiment is balanced, leading to a neutral prediction for stock price movement over the next two weeks.
People Also Watch

LINE
Lineage Inc
43.623
USD
+1.45%

CNA
CNA Financial Corp
44.760
USD
+1.87%

RNR
Renaissancere Holdings Ltd
243.955
USD
-0.56%

POOL
Pool Corp
318.390
USD
-0.96%

GLPI
Gaming and Leisure Properties Inc
45.940
USD
+0.48%

GMAB
Genmab A/S
22.680
USD
-1.78%

CLS
Celestica Inc
200.720
USD
+15.78%

VIV
Telefonica Brasil SA
10.990
USD
+0.55%

WIX
Wix.Com Ltd
149.030
USD
-0.98%

ESLT
Elbit Systems Ltd
451.780
USD
-0.08%
FAQ

What were the key highlights of ITCI’s latest earnings report for FY2024Q3?
ITCI reported its FY2024Q3 earnings on 2024-10-30, showcasing a revenue of 175.38M against an estimate of 172.35M, resulting in a 1.75% surprise. The EPS was -0.25, surpassing the expected -0.18 by -38.89% . The stock experienced a 11.36% price change on the earnings day and a 16.27% change over the next five days, reflecting market reactions to the results.

How did ITCI’s stock price react after the FY2024Q3 earnings release?

What are the revenue and EPS estimates for ITCI for 2025/Q1?

How does ITCI’s stock price correlate with earnings forecast revisions?

What should investors expect from ITCI’s next earnings report?
